Treatment News : Black Women With HIV and Hep C Less Likely to Die of Liver-Related Disease - by Tim Horn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » September 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


September 7, 2012

Black Women With HIV and Hep C Less Likely to Die of Liver-Related Disease

by Tim Horn

Black women living with HIV and hepatitis C virus (HCV) are less likely to die of liver disease, compared with white and Latina women coinfected with both viruses, according to a new analysis of the federally funded Women’s Interagency HIV Study (WIHS) published online ahead of print by the journal Hepatology.

Much is known about the prevalence, course and treatment of chronic HCV infection in blacks, including those coinfected with HIV. The prevalence of HCV is greater among blacks; the virus is less likely to be spontaneously cleared; and it is harder to treat using pegylated interferon-based regimens. However, blacks living with HCV experience less inflammation and fibrosis of their livers compared with whites and Latinos.

Researchers investigating this disparity suggest that the immune response to HCV among blacks is different than that seen in other racial and ethnic populations, a hypothesis that continues to be explored scientifically.

It’s also not clear if the slower progression of HCV disease necessarily translates into a lower risk of deaths related to liver disease, particularly among women and those coinfected with HIV. In turn, Monika Sarkar, MD, of the University of California at San Francisco and her colleagues  analyzed data from the WIHS—established in 1993 to investigate the various affects of HIV, its treatment and its complications among women in the United States—to determine the association between race and ethnicity and liver-related deaths.

The analysis included 794 women coinfected with HIV and HCV; 495 were black, 159 were Latina, and 140 were white. There were 438 deaths and 49 liver-related deaths during the average follow-up period of 8.9 years (with some women followed for up to 16 years).

Among black women, 7.6 percent of the deaths were liver-related, compared with 20.5 percent among Hispanics. This difference was statistically significant, meaning it was too great to have occurred by chance. Roughly 14 percent of the deaths among whites were liver related—compared with black women, however, this higher rate was not statistically significant.

With additional statistical analysis, taking into account differences in CD4 cell counts and viral loads between the groups, Sarkar and her colleagues found that the black women coinfected with HIV and HCV were significantly less likely to die of liver-related disease than either the Latina or white women coinfected with both viruses.

The researchers also conducted analyses to determine if the decrease in liver-related deaths among the black women could be attributed to a higher rate of death from other conditions. Sarkar and her colleagues noted, however, similar risks of mortality from any cause between the three groups.

“[Black] women were much less likely to die from liver disease, as compared to [whites and Latinas], independent of other causes of death,” the authors concluded. “Future studies are needed to investigate the reasons for this marked racial/ethnic discrepancy in liver-related mortality.”

Search: hiv, hepatitis, hcv, women, black, african american, latino, latina, hispanic, white, fibrosis, cirrhosis, mortality, death, progression, wihs

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.